Standout Papers

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults 2015 2026 2018 2022 874
  1. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults (2015)
    Himal Lal, Anthony L. Cunningham et al. New England Journal of Medicine

Citation Impact

Citing Papers

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
Immunosenescence and human vaccine immune responses
2019
Activating a collaborative innate-adaptive immune response to control metastasis
2021
Rheumatoid arthritis
2018 Standout
A guide to vaccinology: from basic principles to new developments
2020
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live
2019
Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
2018
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
2020
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
2016
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)
2019
Emerging concepts in the science of vaccine adjuvants
2021
The emerging safety profile of JAK inhibitors in rheumatic disease
2017
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Varicella zoster virus infection
2015
Risk of gout flares after vaccination: a prospective case cross-over study
2019
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Systematic review of incidence and complications of herpes zoster: towards a global perspective
2014 Standout
From discovery to licensure, the Adjuvant System story
2016
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
2017
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
2018
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Immune correlates of vaccine protection against HIV-1 acquisition
2015
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
2018 Standout
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Gout
2021 Standout
Understanding modern-day vaccines: what you need to know
2017
Surveillance of Vaccination Coverage among Adult Populations — United States, 2015
2017
Post-herpetic neuralgia
2016
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
2019
Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
2019 StandoutNobel
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
2017
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
2016
Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
2019
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
2022 StandoutNobel

Works of Airi Põder being referenced

Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
2017
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Rankless by CCL
2026